טוען...
Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model
Bromocriptine mesylate treatment was examined in dogs fed a high fat diet (HFD) for 8 wk. After 4 wk on HFD, daily bromocriptine (Bromo; n = 6) or vehicle (CTR; n = 5) injections were administered. Oral glucose tolerance tests were performed before beginning HFD (OGTT1), 4 wk after HFD began (Bromo...
שמור ב:
| הוצא לאור ב: | Am J Physiol Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Physiological Society
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7468784/ https://ncbi.nlm.nih.gov/pubmed/32459527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00479.2019 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|